SHL Telemedicine Sets Shareholder Meeting for May 9

TL;DR

SHL Telemedicine calling shareholder meeting May 9th, expect proxy statement details soon.

AI Summary

SHL Telemedicine Ltd. announced on March 26, 2024, that a Special General Meeting of Shareholders will be held on May 9, 2024, at 5:00 p.m. Israel time. The meeting will take place at the Company's offices located at Ashdar Building – 2nd Floor, 90 Yigal Alon Street, Tel Aviv, Israel. The company also published its Proxy Statement in connection with this meeting.

Why It Matters

This filing signals upcoming corporate decisions or votes by shareholders, which could impact the company's strategic direction or governance.

Risk Assessment

Risk Level: low — This is a routine corporate filing announcing a shareholder meeting and the publication of a proxy statement.

Key Players & Entities

• SHL Telemedicine Ltd. (company) — Registrant
• May 9, 2024 (date) — Date of Special General Meeting
• March 26, 2024 (date) — Date of Announcement
• 90 Yigal Alon Street, Tel Aviv, Israel (location) — Company Address

FAQ

Filing Documents

• zk2431180.htm (6-K) — 13KB
• exhibit_99-1.htm (EX-99.1) — 214KB
• exhibit_99-2.htm (EX-99.2) — 57KB
• exhibit_99-3.htm (EX-99.3) — 21KB
• image00001.jpg (GRAPHIC) — 2KB
• image00002.jpg (GRAPHIC) — 2KB
• image00003.jpg (GRAPHIC) — 6KB
• image00006.jpg (GRAPHIC) — 7KB
• 0001178913-24-001063.txt ( ) — 329KB

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number: 001-41641 SHL TELEMEDICINE LTD. (Translation of registrant's name into English) 90 Yigal Alon Street Tel Aviv 67891, Israel (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F INFORMATION CONTAINED IN THIS FORM 6-K REPORT On March 26, 2024, SHL Telemedicine Ltd. (the "Company") announced that a Special General Meeting of Shareholders of the Company (the "Special General Meeting") will be held on Thursday, May 9, 2024, at 5:00 p.m., Israel time, at the offices of the Company at Ashdar Building – 2 nd Floor, 90 Yigal Alon Street, Tel Aviv, Israel, and published its Proxy Statement in connection with the Special General Meeting. The Notice of Special General Meeting of Shareholders and the Proxy Statement in connection with the Special General Meeting are attached hereto as Exhibit 99.1 and are incorporated herein by reference. A copy of the Voting Instruction Form for holders of the Company's American Depositary Shares ("ADSs") being distributed by The Bank of New York Mellon, the Depositary for the Company's ADS program, is attached hereto as Exhibit 99.2 and is incorporated herein by reference. A form of Voting Ballot for holders of the Company's ordinary shares is attached hereto as Exhibit 99.3 and is incorporated herein by reference. This Report on Form 6-K, including the Notice for the Special General Meeting, the Proxy Statement, the Voting Instruction Form for holders of the Company's ADSs and the form of Voting Ballot for holders of the Company's ordinary shares attached to this Report on Form 6-K, will also be made available on the Company's corporate website at www.shl-telemedicine.com . Information contained on, or that can be accessed through, the Company's website, does not constitute a part of this Report on Form 6-K, nor does it form part of the proxy solicitation materials in connection with the Special General Meeting. The Company has included its website address in this Report on Form 6-K solely as an inactive textual reference. The Company will post on its website any materials in connection with the Special General Meeting required to be posted on such website under applicable corporate or securities laws and regulations. Exhibit Description 99.1 Notice of the Special General Meeting of Shareholders of SHL Telemedicine Ltd. and Proxy Statement for the Special General Meeting of Shareholders of SHL Telemedicine Ltd. 99.2 Voting Instruction Form for holders of American Depositary Shares. 99.3 Form of Voting Ballot for holders of Ordinary Shares. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. SHL Telemedicine Ltd. By: /s/ Amir Hai Amir Hai Chief Financial Officer March 26, 2024

View Full Filing

View this 6-K filing on SEC EDGAR